Brian A. Ference

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.4K citations · Full text

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven H J Hageman, Lisa Pennells, Francisco Ojeda et al. · European Heart Journal · 2021 · 1.5K citations · Full text

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Jan Borén, M. John Chapman, Ronald M. Krauss et al. · European Heart Journal · 2020 · 1.4K citations

Therapeutic Insights, Vascular Disease, Epidemiology +13

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes et al. · European Heart Journal · 2022 · 1.1K citations · Full text

Vascular Disease, Cardiometabolic Risk, Hyperlipidemia +22

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis

Tom G. Richardson, Eleanor Sanderson, Tom Palmer et al. · PLoS Medicine · 2020 · 895 citations · Full text